Your Trusted Partner for Pharmacovigilance Support in Bahrain

Bahrain is emerging as a strategically important pharmaceutical market within the Gulf region, supported by progressive healthcare policies, regulatory modernization, and a growing emphasis on patient safety and post-marketing surveillance. However, operating in Bahrain requires companies to establish robust pharmacovigilance systems aligned with national regulatory expectations and regional GCC standards.

Success in Bahrain is no longer limited to product approval; it depends on continuous safety monitoring, regulatory responsiveness, and structured pharmacovigilance compliance.

At DDReg, we provide end-to-end pharmacovigilance services in Bahrain, helping pharmaceutical companies ensure compliance, manage risk, and maintain patient safety across the product lifecycle.

Pharmacovigilance Framework in Bahrain

Pharmacovigilance in Bahrain is regulated by the National Health Regulatory Authority (NHRA), which oversees drug safety monitoring, licensing, and post-marketing surveillance.

The NHRA requires Marketing Authorization Holders (MAHs) to implement effective pharmacovigilance systems to continuously monitor the safety of medicinal products and ensure timely reporting of adverse events.

Normative Framework Governing Pharmacovigilance in Bahrain

Pharmacovigilance compliance in Bahrain is guided by a set of regulatory documents issued by the NHRA:

  • Medicine Licensing Guideline – Defines requirements for obtaining marketing authorization and maintaining product compliance
  • Medicine Variations Guideline – Provides procedures for managing post-approval changes and lifecycle updates
  • Medicines Barcoding and Serialization Guideline – Mandates GS1 DataMatrix barcoding to enhance traceability and combat counterfeit medicines

These frameworks highlight Bahrain’s increasing focus on traceability, transparency, and lifecycle safety management.

QPPV and Pharmacovigilance Requirements in Bahrain

  • Pharmacovigilance System Requirements
    • MAHs must establish and maintain a functioning pharmacovigilance system
    • Must ensure continuous monitoring of product safety post-marketing
  • Qualified Person for Pharmacovigilance (QPPV)
    • Appointment of a QPPV is required
    • Must be:
      • Appropriately qualified and experienced in pharmacovigilance
      • Readily available to communicate with the NHRA

Our Pharmacovigilance Services in Bahrain

DDReg delivers comprehensive drug safety services in Bahrain, ensuring full alignment with NHRA requirements and global pharmacovigilance standards.

  • + Individual Case Safety Report (ICSR) Management
  • + Aggregate Reporting & Safety Writing
  • + Signal Detection & Risk Management
  • + QPPV Services & PV System Setup
  • + Literature Screening & Safety Intelligence
  • + Pharmacovigilance Consulting Services in Bahrain

Why Choose DDReg as Your Pharmacovigilance Company in Bahrain?

Strong understanding of Bahrain’s regulatory environment and GCC harmonization trends.

End-to-End Drug Safety Services

Comprehensive support from clinical development to post-marketing.

Compliance-Focused Approach

Ensuring adherence to NHRA guidelines and global best practices.

Inspection-Ready Systems

Prepared for audits and regulatory inspections.

Technology-Enabled Solutions

Advanced tools for efficient safety data management and reporting.

                          Global Reach Explorer

                          Find Your Solution

                          Progress0 / 3 selected

                          Our Pharmacovigilance (PV) Services Expertise

                          ICSR Case Processing and Submission
                          01

                          ICSR Case Processing and Submission

                          Our advanced Individual Case Safety Report (ICSR) Pharmacovigilance Services are dedicated to ensuring patient safety through precise case handling....

                          Literature Monitoring
                          02

                          Literature Monitoring

                          DDReg’s Literature Monitoring Services offer advanced pharmacovigilance literature screening for drug safety. We help Marketing...

                           Risk Management
                          03

                          Risk Management

                          Our expert risk management solutions ensure patient safety by proactively addressing potential hazards in pharmaceutical...

                          Audit and Compliance
                          04

                          Audit and Compliance

                          Our specialized services ensure that pharmacovigilance systems across the drug development pipeline meet strict regulatory...

                          Pharmacovigilance Signal Management Services
                          05

                          Pharmacovigilance Signal Management Services

                          DDReg’s specialized pharmacovigilance services ensure that potential adverse events are identified and addressed promptly...

                          QPPV Services
                          06

                          QPPV Services

                          DDReg’s expert team provides comprehensive QPPV services designed to strengthen your pharmacovigilance system. We ensure that...

                          Aggregate Safety Reports Services
                          07

                          Aggregate Safety Reports Services

                          DDReg’s comprehensive aggregate safety reports services deliver a detailed benefit‐risk evaluation for pharmaceutical products....

                          Connect with DDReg today for trusted, compliant, and scalable pharmacovigilance services in Bahrain.

                          Frequently Asked
                          Questions

                          01
                          02
                          03
                          04
                          Get in Touch

                          Recommended for You